Balter Liquid Alternatives LLC increased its holdings in shares of Invacare Co. (NYSE:IVC) by 22.0% in the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 71,881 shares of the health services provider’s stock after purchasing an additional 12,939 shares during the quarter. Invacare accounts for 1.2% of Balter Liquid Alternatives LLC’s holdings, making the stock its 18th biggest position. Balter Liquid Alternatives LLC’s holdings in Invacare were worth $1,211,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also bought and sold shares of IVC. The Manufacturers Life Insurance Company grew its stake in shares of Invacare by 0.5% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 25,974 shares of the health services provider’s stock worth $343,000 after acquiring an additional 119 shares in the last quarter. Thrivent Financial For Lutherans grew its stake in shares of Invacare by 7.7% during the 2nd quarter. Thrivent Financial For Lutherans now owns 19,470 shares of the health services provider’s stock worth $257,000 after acquiring an additional 1,390 shares in the last quarter. Voya Investment Management LLC grew its stake in shares of Invacare by 10.5% during the 2nd quarter. Voya Investment Management LLC now owns 17,271 shares of the health services provider’s stock worth $228,000 after acquiring an additional 1,648 shares in the last quarter. Principal Financial Group Inc. grew its stake in shares of Invacare by 1.5% during the 3rd quarter. Principal Financial Group Inc. now owns 258,442 shares of the health services provider’s stock worth $4,070,000 after acquiring an additional 3,888 shares in the last quarter. Finally, Schwab Charles Investment Management Inc. grew its stake in shares of Invacare by 1.1% during the 3rd quarter. Schwab Charles Investment Management Inc. now owns 372,935 shares of the health services provider’s stock worth $5,874,000 after acquiring an additional 4,218 shares in the last quarter.

Several equities analysts have recently weighed in on IVC shares. Zacks Investment Research raised shares of Invacare from a “sell” rating to a “hold” rating in a research note on Wednesday, January 31st. KeyCorp reaffirmed a “buy” rating and set a $20.00 price target on shares of Invacare in a research note on Thursday, December 21st. Finally, ValuEngine raised shares of Invacare from a “sell” rating to a “hold” rating in a research note on Sunday, December 31st. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and two have assigned a buy rating to the stock. The stock presently has a consensus rating of “Hold” and an average target price of $16.50.

Invacare Co. (NYSE:IVC) opened at $18.50 on Friday. The firm has a market cap of $724.96, a P/E ratio of -7.87 and a beta of 2.55. Invacare Co. has a 52 week low of $10.20 and a 52 week high of $19.05. The company has a debt-to-equity ratio of 0.57, a quick ratio of 1.57 and a current ratio of 2.10.

Invacare (NYSE:IVC) last issued its quarterly earnings results on Wednesday, February 7th. The health services provider reported ($0.42) earnings per share for the quarter, topping the consensus estimate of ($0.44) by $0.02. The company had revenue of $250.35 million during the quarter, compared to analysts’ expectations of $241.07 million. Invacare had a negative net margin of 7.92% and a negative return on equity of 14.95%. The business’s quarterly revenue was up 1.5% on a year-over-year basis. During the same period last year, the business earned ($0.46) EPS. equities research analysts predict that Invacare Co. will post -1.16 earnings per share for the current fiscal year.

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, January 16th. Stockholders of record on Thursday, January 4th were issued a $0.0125 dividend. This represents a $0.05 annualized dividend and a dividend yield of 0.27%. The ex-dividend date of this dividend was Wednesday, January 3rd. Invacare’s payout ratio is presently -2.13%.

TRADEMARK VIOLATION NOTICE: “Balter Liquid Alternatives LLC Boosts Position in Invacare Co. (IVC)” was originally published by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are accessing this article on another publication, it was stolen and reposted in violation of US and international trademark & copyright laws. The correct version of this article can be viewed at https://theolympiareport.com/2018/02/11/balter-liquid-alternatives-llc-boosts-position-in-invacare-co-ivc.html.

Invacare Company Profile

Invacare Corporation is a manufacturer and distributor for medical equipment used in non-acute care settings. The Company’s geographical segments are Europe; North America, which includes North America/Home Medical Equipment (North America/HME) and Institutional Products Group (IPG) segments, and Asia/Pacific.

Want to see what other hedge funds are holding IVC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Invacare Co. (NYSE:IVC).

Institutional Ownership by Quarter for Invacare (NYSE:IVC)

Receive News & Ratings for Invacare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invacare and related companies with MarketBeat.com's FREE daily email newsletter.